Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 9 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-11-09 F6 · shares: The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price. F7 · derivative.exercise_date: The option vests monthly over a period of three years commencing 11/9/2016. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 8 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-06-19 F5 · derivative.exercise_date: The option vests monthly over a period of four years commencing 6/19/2016. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 7 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-06-19 F4 · shares: The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price. F5 · derivative.exercise_date: The option vests monthly over a period of four years commencing 6/19/2016. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 6 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2021-04-26 Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 5 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2021-04-26 F3 · shares: The reporting person agreed to cancellation of an option granted to him on 4/26/2011 in exchange for a new option having a lower exercise price. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 4 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2019-12-30 Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 3 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2019-12-30 F2 · shares: The reporting person agreed to cancellation of an option granted to him on 12/30/2009 in exchange for a new option having a lower exercise price. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 2 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2019-11-04 Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:22 UTC |
Underdown Brian J.Director
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001415889-18-001316 · form4-08312018_020836.xml · derivative · entry 1 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2019-11-04 F1 · shares: The reporting person agreed to cancellation of an option granted to him on 11/4/2009 in exchange for a new option having a lower exercise price. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:21 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-18-001315 · form4-08312018_020812.xml · derivative · entry 6 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-04-26 F6 · derivative.exercise_date: The option vests monthly over a period of three years commencing 4/26/2017. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:21 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-18-001315 · form4-08312018_020812.xml · derivative · entry 5 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2027-04-26 F5 · shares: The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price. F6 · derivative.exercise_date: The option vests monthly over a period of three years commencing 4/26/2017. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:21 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-18-001315 · form4-08312018_020812.xml · derivative · entry 4 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2026-11-09 F4 · derivative.exercise_date: The option vests monthly over a period of three years commencing 11/9/2016. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:21 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-18-001315 · form4-08312018_020812.xml · derivative · entry 3 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2026-11-09 F3 · shares: The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price. F4 · derivative.exercise_date: The option vests monthly over a period of three years commencing 11/9/2016. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:21 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-18-001315 · form4-08312018_020812.xml · derivative · entry 2 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2026-06-19 F2 · derivative.exercise_date: The option vests monthly over a period of four years commencing 6/19/2016. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 21:21 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001415889-18-001315 · form4-08312018_020812.xml · derivative · entry 1 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 180,000 shares Expires 2026-06-19 F1 · shares: The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price. F2 · derivative.exercise_date: The option vests monthly over a period of four years commencing 6/19/2016. Read SEC document |
| August 05, 2018 Filed Aug 6, 2018 17:00 UTC |
GIN JERRY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001415889-18-001230 · form4-08062018_020813.xml · derivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-08-05 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter. Read SEC document |
| August 05, 2018 Filed Aug 6, 2018 16:57 UTC |
SAXE JON SDirector
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001415889-18-001229 · form4-08062018_010829.xml · derivative · entry 1 SAXE JON S · CIK 0001114914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-08-05 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter. Read SEC document |
| August 05, 2018 Filed Aug 6, 2018 16:52 UTC |
SNODGRASS H. RALPHDirector · PRES./CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001415889-18-001225 · form4-08062018_010833.xml · derivative · entry 1 SNODGRASS H. RALPH · CIK 0001415876 · Director · PRES./CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-08-05 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter. Read SEC document |
| August 05, 2018 Filed Aug 6, 2018 20:53 UTC |
MCPARTLAND MARK A.VP CORPORATE DEVELOPMENT
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001415889-18-001226 · form4-08062018_010833.xml · derivative · entry 1 MCPARTLAND MARK A. · CIK 0001620140 · VP CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-08-05 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter. Read SEC document |
| August 05, 2018 Filed Aug 6, 2018 20:55 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001415889-18-001228 · form4-08062018_010806.xml · derivative · entry 1 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-08-05 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter. Read SEC document |
| August 05, 2018 Filed Aug 6, 2018 20:54 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001415889-18-001227 · form4-08062018_010818.xml · derivative · entry 1 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-08-05 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter. Read SEC document |
| August 05, 2018 Filed Aug 6, 2018 20:38 UTC |
DOTSON JERROLD DUANECFO AND SECRETARY
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001415889-18-001224 · form4-08062018_010826.xml · derivative · entry 1 DOTSON JERROLD DUANE · CIK 0001388853 · CFO AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-08-05 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 16:53 UTC |
GIN JERRY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001415889-18-000183 · form4-02052018_010200.xml · derivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-02-02 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 16:54 UTC |
SAXE JON SDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001415889-18-000185 · form4-02052018_010248.xml · derivative · entry 1 SAXE JON S · CIK 0001114914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-02-02 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 16:56 UTC |
SNODGRASS H. RALPHDirector · PRES./CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001415889-18-000189 · form4-02052018_010215.xml · derivative · entry 1 SNODGRASS H. RALPH · CIK 0001415876 · Director · PRES./CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2028-02-02 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 21:55 UTC |
Singh ShawnDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001415889-18-000187 · form4-02052018_010209.xml · derivative · entry 1 Singh Shawn · CIK 0001412071 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-02-02 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 21:57 UTC |
MCPARTLAND MARK A.VP CORPORATE DEVELOPMENT
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001415889-18-000190 · form4-02052018_010205.xml · derivative · entry 1 MCPARTLAND MARK A. · CIK 0001620140 · VP CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-02-02 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 21:54 UTC |
DOTSON JERROLD DUANECFO AND SECRETARY
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001415889-18-000186 · form4-02052018_010234.xml · derivative · entry 1 DOTSON JERROLD DUANE · CIK 0001388853 · CFO AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-02-02 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 21:55 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001415889-18-000188 · form4-02052018_010240.xml · derivative · entry 1 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-02-02 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 21:52 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001415889-18-000182 · form4-02052018_010218.xml · derivative · entry 1 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-02-02 F1 · derivative.exercise_date: 25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter. Read SEC document |
| September 19, 2017 Filed Sep 20, 2017 16:35 UTC |
GIN JERRY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001415889-17-001524 · form4-09202017_010957.xml · derivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-19 F1 · derivative.exercise_date: 1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date. Read SEC document |
| September 19, 2017 Filed Sep 20, 2017 16:31 UTC |
SAXE JON SDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001415889-17-001518 · form4-09202017_010916.xml · derivative · entry 1 SAXE JON S · CIK 0001114914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-19 F1 · derivative.exercise_date: 1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date. Read SEC document |
| September 19, 2017 Filed Sep 20, 2017 16:33 UTC |
SNODGRASS H. RALPHDirector · PRES./CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001415889-17-001521 · form4-09202017_010913.xml · derivative · entry 1 SNODGRASS H. RALPH · CIK 0001415876 · Director · PRES./CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-09-19 F1 · derivative.exercise_date: 1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date. Read SEC document |
| September 19, 2017 Filed Sep 20, 2017 20:33 UTC |
Singh ShawnDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001415889-17-001522 · form4-09202017_010944.xml · derivative · entry 1 Singh Shawn · CIK 0001412071 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-09-19 F1 · derivative.exercise_date: 1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date. Read SEC document |
| September 19, 2017 Filed Sep 20, 2017 20:34 UTC |
Underdown Brian J.Director
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001415889-17-001523 · form4-09202017_010926.xml · derivative · entry 1 Underdown Brian J. · CIK 0001526335 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-19 F1 · derivative.exercise_date: 1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date. Read SEC document |
| September 19, 2017 Filed Sep 20, 2017 20:32 UTC |
Smith Mark AlanCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001415889-17-001520 · form4-09202017_010935.xml · derivative · entry 1 Smith Mark Alan · CIK 0001677452 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-09-19 F1 · derivative.exercise_date: 1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date. Read SEC document |
| September 19, 2017 Filed Sep 20, 2017 20:32 UTC |
DOTSON JERROLD DUANECFO AND SECRETARY
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001415889-17-001519 · form4-09202017_010956.xml · derivative · entry 1 DOTSON JERROLD DUANE · CIK 0001388853 · CFO AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-09-19 F1 · derivative.exercise_date: 1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date. Read SEC document |
| September 19, 2017 Filed Oct 6, 2017 17:30 UTC Amendment |
GIN JERRY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0001415889-17-001635 · form4a-10062017_021041.xml · derivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-19 F1 · derivative.exercise_date: 1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date. Read SEC document |
| September 15, 2017 Filed Oct 6, 2017 17:30 UTC Amendment |
GIN JERRY BDirector
|
GrantWarrants · Derivative | 25,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001635 · form4a-10062017_021041.xml · derivative · entry 7 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2021-04-30 F2 · price: This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the "Original Filing") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person ("Jermax"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the "Initial Warrants") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the "Additional Warrants"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the "Spring 2017 Private Placement"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement. Read SEC document |
| September 15, 2017 Filed Oct 6, 2017 17:30 UTC Amendment |
GIN JERRY BDirector
|
GrantWarrant · Derivative | 25,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001635 · form4a-10062017_021041.xml · derivative · entry 6 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Jermax, LLC Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2021-04-30 F2 · price: This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the "Original Filing") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person ("Jermax"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the "Initial Warrants") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the "Additional Warrants"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the "Spring 2017 Private Placement"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement. Read SEC document |
| September 15, 2017 Filed Oct 6, 2017 17:30 UTC Amendment |
GIN JERRY BDirector
|
GrantWarrant · Derivative | 25,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001635 · form4a-10062017_021041.xml · derivative · entry 5 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2021-04-30 F2 · price: This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the "Original Filing") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person ("Jermax"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the "Initial Warrants") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the "Additional Warrants"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the "Spring 2017 Private Placement"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement. Read SEC document |
| September 15, 2017 Filed Oct 6, 2017 17:30 UTC Amendment |
GIN JERRY BDirector
|
GrantWarrant · Derivative | 25,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001635 · form4a-10062017_021041.xml · derivative · entry 4 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Jermax, LLC Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2021-04-30 F2 · price: This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the "Original Filing") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person ("Jermax"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the "Initial Warrants") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the "Additional Warrants"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the "Spring 2017 Private Placement"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement. Read SEC document |
| September 15, 2017 Filed Oct 6, 2017 17:30 UTC Amendment |
GIN JERRY BDirector
|
Disposition to issuerWarrant · Derivative | 25,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001635 · form4a-10062017_021041.xml · derivative · entry 3 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-04-30 F2 · price: This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the "Original Filing") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person ("Jermax"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the "Initial Warrants") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the "Additional Warrants"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the "Spring 2017 Private Placement"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement. Read SEC document |
| September 15, 2017 Filed Oct 6, 2017 17:30 UTC Amendment |
GIN JERRY BDirector
|
Disposition to issuerWarrant · Derivative | 25,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001415889-17-001635 · form4a-10062017_021041.xml · derivative · entry 2 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Jermax, LLC Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-04-30 F2 · price: This Amendment to the Form 4 originally filed by the Reporting Person on September 20, 2017 (the "Original Filing") is being filed to report (i) the reduction of the exercise price of warrants purchased by Jermax, LLC, an entity controlled by the Reporting Person ("Jermax"), and the Reporting Person's spouse from the Issuer on May 31, 2017 in a private placement transaction (the "Initial Warrants") and (ii) the issuance of additional warrants to Jermax and the Reporting Person's spouse (the "Additional Warrants"). The Issuer's Board of Directors approved the reduction of the exercise price from $4.00 per share to $2.00 per share for the Initial Warrants and all other warrants issued in the same private placement (the "Spring 2017 Private Placement"), and the issuance of the Additional Warrants and warrants similar to the Additional Warrants for all other participants in the Spring 2017 Private Placement. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:56 UTC |
GIN JERRY BDirector
|
PurchaseWarrant · Derivative | 25,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001415889-17-000882 · form4-06012017_010655.xml · derivative · entry 4 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires 2021-04-30 F3 · security: Reporting Person's spouse purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share. F4 · ownership.nature: Shares are held by Pegmax, LLC, which is wholly owned and controlled by the Reporting Person's spouse, Margaret P. Gin. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:56 UTC |
GIN JERRY BDirector
|
PurchaseWarrant · Derivative | 25,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001415889-17-000882 · form4-06012017_010655.xml · derivative · entry 3 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Jermax, LLC Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2021-04-30 F1 · security: Reporting Person purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share. F2 · ownership.nature: Jermax, LLC is wholly owned and controlled by the Reporting Person. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:56 UTC |
GIN JERRY BDirector
|
PurchaseCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-17-000882 · form4-06012017_010655.xml · nonDerivative · entry 2 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 100,000 F3 · price: Reporting Person's spouse purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share. F4 · ownership.nature: Shares are held by Pegmax, LLC, which is wholly owned and controlled by the Reporting Person's spouse, Margaret P. Gin. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:56 UTC |
GIN JERRY BDirector
|
PurchaseCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-17-000882 · form4-06012017_010655.xml · nonDerivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Jermax, LLC Disclosed balance after: 50,000 F1 · price: Reporting Person purchased fifty thousand (50,000) Units, at a per-Unit cost of two dollars ($2.00), in the Issuer's private placement, each Unit consisting of one (1) share of unregistsered Common Stock and a warrant to purchase one-half (0.5) share of unregistered Common Stock at an exercise price of $4.00 per share. F2 · ownership.nature: Jermax, LLC is wholly owned and controlled by the Reporting Person. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 15:30 UTC |
GIN JERRY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-17-000678 · form4-04282017_120446.xml · derivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-04-26 F1 · derivative.exercise_date: One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 15:33 UTC |
SAXE JON SDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-17-000683 · form4-04282017_120442.xml · derivative · entry 1 SAXE JON S · CIK 0001114914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-04-26 F1 · derivative.exercise_date: One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.